+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Solutions Market by Product Type (Colloids, Crystalloids), End User (Ambulatory Care, Home Healthcare Providers, Hospitals), Application, Distribution Channel, Packaging Type - Global Forecast 2025-2030- Product Image
Intravenous Solutions Market by Product Type (Colloids, Crystalloids), End User (Ambulatory Care, Home Healthcare Providers, Hospitals), Application, Distribution Channel, Packaging Type - Global Forecast 2025-2030- Product Image
Sale

Intravenous Solutions Market by Product Type (Colloids, Crystalloids), End User (Ambulatory Care, Home Healthcare Providers, Hospitals), Application, Distribution Channel, Packaging Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454935
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The intravenous solutions market is evolving swiftly, with healthcare providers globally integrating new formulations and delivery technologies to meet complex patient needs. Senior leaders should monitor this sector’s transformation as it relates both to clinical advancements and operational realities within modern healthcare delivery.

Market Snapshot: Intravenous Solutions Market Size and Growth Outlook

The intravenous solutions market grew from USD 14.99 billion in 2024 to USD 16.38 billion in 2025 and is projected to continue rising at a 9.18% CAGR, reaching USD 25.40 billion by 2030. Expanding patient populations, technological innovation, and evolving regulatory landscapes are shaping the market. Demand spans acute care hospitals, outpatient settings, and home infusion services as providers focus on effective hydration, drug delivery, and nutritional support across varied clinical contexts.

Scope & Segmentation of the Intravenous Solutions Market

  • Product Types: Colloid solutions (albumin, synthetic variants); crystalloid solutions (balanced formulations, standard normal saline).
  • End Users: Hospitals, ambulatory care clinics, home healthcare providers.
  • Applications: Critical care therapies, emergency department use, nutritional support, surgical and perioperative fluid management.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacy outlets.
  • Packaging Types: Single-use bottles, concentrated fluids for dilution, pre-mixed intravenous bags.
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (notably China, India, Japan, Australia, and key Southeast Asian markets).
  • Industry Players: Major contributors include Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, Grifols S.A., ICU Medical, Inc., Pfizer Inc., Terumo Corporation, Laboratoires Aguettant S.A., Macopharma S.A.S., and Nipro Corporation.
  • Technological Features: Automated compounding equipment, closed-system delivery devices, smart infusion monitoring tools, advanced sterile packaging solutions.

Key Takeaways for Senior Decision-Makers

  • Adoption of automated compounding and digital infusion platforms drives consistency and safety in solution administration.
  • Personalized treatment is advancing, with data analytics tools predicting patient fluid requirements and detecting infusion anomalies.
  • Rising prevalence of chronic illnesses and increased critical care episodes are expanding demand for both specialized and standard intravenous fluids.
  • Strategic partnerships and collaborative innovation help streamline regulatory compliance and improve time-to-market for novel solution types.
  • Packaging innovations such as pre-mixed bags promote workflow efficiency and meet stricter contamination control requirements.
  • Regional differences in regulations, reimbursement, and healthcare infrastructure require adaptive go-to-market and supply strategies.

Tariff Impact: Navigating 2025 United States Trade Policy Changes

Recent U.S. tariff adjustments on raw materials and packaging components are increasing cost pressures across the intravenous solutions supply chain. Manufacturers are responding by reengineering sourcing strategies, investing in localized production, and forming strategic alliances with domestic suppliers. Healthcare providers are adapting inventory planning and vendor management to preserve supply continuity, though these efforts may lead to higher operating costs for critical therapies.

Methodology & Data Sources

This report employs a rigorous multi-step approach, combining detailed literature reviews, structured interviews with industry and clinical experts, and thorough data validation using triangulation. Qualitative insights from senior executives, pharmacists, and procurement professionals are synthesized alongside secondary research from regulatory filings and peer-reviewed journals. Analytical techniques include both scenario modeling and thematic analysis, with findings subject to external peer review for accuracy and relevance.

Why This Report Matters for Decision-Makers

  • Enables procurement and clinical teams to benchmark technologies and distribution models against evolving regulatory expectations and quality standards.
  • Supports supply chain leaders in mitigating cost and access risks associated with global sourcing, tariffs, and regional policy shifts.
  • Empowers executives with strategic segmentation and regional insights, aiding effective resource allocation and market entry planning in a changing landscape.

Conclusion

The intravenous solutions market is defined by ongoing transformation in technology, regulation, and demand drivers. Senior leaders focused on resilience, innovation, and compliance will be best positioned to deliver therapeutic value and organizational growth in this essential sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing integration of AI-driven personalized fluid therapy protocols in hospitals
5.2. Expansion of biosimilar intravenous solutions to address cost pressures in emerging markets
5.3. Deployment of closed system transfer devices to improve safety and reduce medication waste
5.4. Adoption of smart infusion pumps with wireless connectivity for real-time dose monitoring
5.5. Shift toward pH-balanced and electrolyte-optimized premixed solutions to improve patient outcomes
5.6. Implementation of continuous renal replacement therapy fluids tailored for pediatric critical care
5.7. Surge in eco-friendly packaging initiatives for intravenous solution containers in Europe
5.8. Integration of blockchain tracking for intravenous solutions to enhance supply chain transparency
5.9. Growth in demand for high-concentration nutrient admixtures in home infusion therapy settings
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intravenous Solutions Market, by Product Type
8.1. Introduction
8.2. Colloids
8.2.1. Albumin
8.2.2. Synthetic Colloids
8.3. Crystalloids
8.3.1. Balanced Solutions
8.3.2. Normal Saline
9. Intravenous Solutions Market, by End User
9.1. Introduction
9.2. Ambulatory Care
9.3. Home Healthcare Providers
9.4. Hospitals
10. Intravenous Solutions Market, by Application
10.1. Introduction
10.2. Critical Care
10.3. Emergency Care
10.4. Nutritional Support
10.5. Surgical Procedures
11. Intravenous Solutions Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Intravenous Solutions Market, by Packaging Type
12.1. Introduction
12.2. Bottles
12.3. Concentrates
12.4. Pre-Mixed Bags
13. Americas Intravenous Solutions Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Intravenous Solutions Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Intravenous Solutions Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Baxter International Inc.
16.3.2. Fresenius Kabi AG
16.3.3. B. Braun Melsungen AG
16.3.4. Grifols, S.A.
16.3.5. ICU Medical, Inc.
16.3.6. Pfizer Inc.
16.3.7. Terumo Corporation
16.3.8. Laboratoires Aguettant S.A.
16.3.9. Macopharma S.A.S.
16.3.10. Nipro Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. INTRAVENOUS SOLUTIONS MARKET: RESEARCHAI
FIGURE 26. INTRAVENOUS SOLUTIONS MARKET: RESEARCHSTATISTICS
FIGURE 27. INTRAVENOUS SOLUTIONS MARKET: RESEARCHCONTACTS
FIGURE 28. INTRAVENOUS SOLUTIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SYNTHETIC COLLOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SYNTHETIC COLLOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY BALANCED SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY BALANCED SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY BOTTLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY BOTTLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CONCENTRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CONCENTRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRE-MIXED BAGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRE-MIXED BAGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 96. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 97. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 98. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 99. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 112. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 113. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 184. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 185. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 192. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 193. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 198. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 199. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 206. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 221. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 224. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 225. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 226. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 227. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 234. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 235. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 240. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 241. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 248. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 291. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 296. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 297. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 304. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 319. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2024 (USD MILLION)
TABLE 322. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2025-2030 (USD MILLION)
TABLE 323. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2024 (USD MILLION)
TABLE 324. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2025-2030 (USD MILLION)
TABLE 325. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 332. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 333. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 33

Samples

Loading
LOADING...

Companies Mentioned

  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Terumo Corporation
  • Laboratoires Aguettant S.A.
  • Macopharma S.A.S.
  • Nipro Corporation

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.4 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

IV Solution Bags Market by Product Type (Multi Chamber, Single Chamber), Application (Blood Transfusion, Chemotherapy, General Infusion Therapy), End User, Material Type, Sales Channel - Global Forecast 2025-2030 - Product Image

IV Solution Bags Market by Product Type (Multi Chamber, Single Chamber), Application (Blood Transfusion, Chemotherapy, General Infusion Therapy), End User, Material Type, Sales Channel - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Intravenous (IV) Solutions - Global Strategic Business Report - Product Image

Intravenous (IV) Solutions - Global Strategic Business Report

  • Report
  • 487 Pages
  • Global
From
Intravenous Solutions Market Overview, 2025-30 - Product Image

Intravenous Solutions Market Overview, 2025-30

  • Report
  • 101 Pages
  • Global
From
Intravenous Solutions Market Outlook, 2030 - Product Image

Intravenous Solutions Market Outlook, 2030

  • Report
  • 181 Pages
  • Global
From
Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033 - Product Image

Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033

  • Report
  • 144 Pages
  • Global
From

About the IV Solution Market

The IV Solution market is a segment of the medical device industry that focuses on the production and distribution of intravenous solutions. These solutions are used to deliver medications, nutrients, and other fluids directly into a patient's bloodstream. IV solutions are typically packaged in bags, bottles, or syringes and are available in a variety of concentrations and sizes. They are used in a variety of medical settings, including hospitals, clinics, and home care. The IV Solution market is highly competitive, with a wide range of products available from a variety of manufacturers. Companies in the market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, ICU Medical, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.